ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HCWB HCW Biologics Inc

1.41
0.00 (0.00%)
Pre Market
Last Updated: 03:00:00
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 1.29
Ask Price 1.63
News -
Day High

Low
0.91

52 Week Range

High
2.32

Day Low
Share Name Share Symbol Market Stock Type
HCW Biologics Inc HCWB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.41 03:00:00
Open Price Low Price High Price Close Price Previous Close
1.41
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.91 - 2.32
Last Trade Type Quantity Price Currency
- 0 US$ 1.41 USD

HCW Biologics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
50.72M 35.97M - 2.84M -24.99M -0.69 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

HCW Biologics News

Date Time Source News Article
4/01/202415:10GlobeNewswire Inc.HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year..
2/27/202415:27Edgar (US Regulatory)Form D - Notice of Exempt Offering of Securities
2/22/202413:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202413:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202413:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202413:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/22/202407:39Edgar (US Regulatory)Form 8-K - Current report
1/12/202406:30Edgar (US Regulatory)Form 8-K - Current report
12/11/202315:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/11/202315:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/20/202315:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/14/202306:00GlobeNewswire Inc.HCW Biologics Reports Third Quarter 2023 Financial Results..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HCWB Message Board. Create One! See More Posts on HCWB Message Board See More Message Board Posts

Historical HCWB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.611.631.351.523,411-0.20-12.42%
1 Month1.651.931.351.636,578-0.24-14.55%
3 Months1.161.931.101.5416,4090.2521.55%
6 Months1.701.930.911.4016,995-0.29-17.06%
1 Year1.332.320.911.6215,0640.086.02%
3 Years7.507.510.914.42304,858-6.09-81.20%
5 Years7.507.510.914.42304,858-6.09-81.20%

HCW Biologics Description

HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.

Your Recent History

Delayed Upgrade Clock